Jiangsu Hualan New Pharmaceutical MaterialLtd Past Earnings Performance
Past criteria checks 2/6
Jiangsu Hualan New Pharmaceutical MaterialLtd's earnings have been declining at an average annual rate of -5.3%, while the Medical Equipment industry saw earnings growing at 8% annually. Revenues have been declining at an average rate of 4.1% per year. Jiangsu Hualan New Pharmaceutical MaterialLtd's return on equity is 4.1%, and it has net margins of 16.1%.
Key information
-5.3%
Earnings growth rate
-13.8%
EPS growth rate
Medical Equipment Industry Growth | 16.0% |
Revenue growth rate | -4.1% |
Return on equity | 4.1% |
Net Margin | 16.1% |
Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Jiangsu Hualan New Pharmaceutical MaterialLtd makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Mar 24 | 593 | 95 | 146 | 39 |
31 Dec 23 | 623 | 118 | 144 | 36 |
30 Sep 23 | 631 | 106 | 161 | 36 |
30 Jun 23 | 619 | 98 | 155 | 37 |
31 Mar 23 | 610 | 96 | 148 | 36 |
01 Jan 23 | 584 | 94 | 141 | 37 |
30 Sep 22 | 586 | 108 | 132 | 39 |
30 Jun 22 | 691 | 164 | 135 | 41 |
31 Mar 22 | 784 | 206 | 142 | 44 |
01 Jan 22 | 821 | 216 | 144 | 42 |
30 Sep 21 | 784 | 214 | 122 | 37 |
30 Jun 21 | 633 | 151 | 108 | 31 |
31 Mar 21 | 509 | 103 | 88 | 25 |
31 Dec 20 | 446 | 81 | 77 | 24 |
31 Dec 19 | 460 | 95 | 89 | 20 |
31 Dec 18 | 434 | 86 | 79 | 21 |
31 Dec 17 | 388 | 77 | 68 | 16 |
Quality Earnings: 301093 has high quality earnings.
Growing Profit Margin: 301093's current net profit margins (16.1%) are higher than last year (15.7%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 301093's earnings have declined by 5.3% per year over the past 5 years.
Accelerating Growth: 301093's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 301093 had negative earnings growth (-0.5%) over the past year, making it difficult to compare to the Medical Equipment industry average (-1.3%).
Return on Equity
High ROE: 301093's Return on Equity (4.1%) is considered low.